LifeStance Health Share Holder Equity 2020-2023 | LFST
LifeStance Health share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
| LifeStance Health Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023 | $1,429 |
| 2022 | $1,519 |
| 2021 | $1,545 |
| 2020 | $998 |
| 2019 | $-166 |
| LifeStance Health Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-12-31 | $1,429 |
| 2023-09-30 | $1,455 |
| 2023-06-30 | $1,495 |
| 2023-03-31 | $1,505 |
| 2022-12-31 | $1,519 |
| 2022-09-30 | $1,532 |
| 2022-06-30 | $1,531 |
| 2022-03-31 | $1,543 |
| 2021-12-31 | $1,545 |
| 2021-09-30 | $1,545 |
| 2021-06-30 | $1,545 |
| 2021-03-31 | $954 |
| 2020-12-31 | $998 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $-166 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.622B | $1.056B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.429B | 10.54 |
| Quest Diagnostics (DGX) | United States | $15.377B | 15.89 |
| DaVita (DVA) | United States | $12.061B | 14.98 |
| Encompass Health (EHC) | United States | $8.712B | 22.30 |
| Chemed (CHE) | United States | $8.709B | 26.99 |
| Elanco Animal Health (ELAN) | United States | $8.401B | 21.80 |
| Option Care Health (OPCH) | United States | $5.235B | 19.82 |
| RadNet (RDNT) | United States | $4.083B | 85.00 |
| Amedisys (AMED) | United States | $3.121B | 22.11 |
| Astrana Health (ASTH) | United States | $2.179B | 29.46 |
| Addus HomeCare (ADUS) | United States | $1.789B | 25.59 |
| U.S Physical Therapy (USPH) | United States | $1.603B | 42.90 |
| Pennant (PNTG) | United States | $0.680B | 35.94 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.481B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.316B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |